A top podcast for healthcare leaders, with over one million downloads, Radio Advisory is your weekly download on how to untangle the industry's most pressing challenges to help leaders like you make the best business decisions for your organization. From unpacking major trends in care delivery—like site-of-care shifts and the rise of high-cost drugs—to demystifying stakeholder dynamics, to shining a spotlight on priorities that may get overlooked, we're here to help. Our hosts and seasoned r ...
…
continue reading
Player FM - Internet Radio Done Right
Checked 6d ago
추가했습니다 three 년 전
PwC's Health Industries에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 PwC's Health Industries 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
PwC's Next in Health와 비슷한 콘텐츠
Call them changemakers. Call them rule breakers. We call them Redefiners. And in this provocative podcast, we explore how daring leaders from across industries and around the globe are redefining their organizations—and themselves—to create extraordinary impact in today’s rapidly changing world. In each episode, Russell Reynolds Associates Leadership Advisor Hoda Tahoun and former CEO Clarke Murphy host engaging, purposeful conversations with leaders in and out of the business world who shar ...
…
continue reading
Rachel Cooke is your guide to leadership and communication, helping you craft a workplace environment you can feel good about. She’ll share tips to help you balance your work and personal life, effectively invest your time, and be mindful about where you’re devoting your energy. Let Rachel help you navigate your path to success—however you define it.
…
continue reading
Wharton faculty and industry leaders discuss their latest research, books, and relevant business topics. Hosted on Acast. See acast.com/privacy for more information.
…
continue reading
Some Goodness is hosted by Richard Ellis, a seasoned sales leader passionate about inviting top business minds to share their wisdom. Each episode is only 15-20 minutes, perfect for your commute or workout.
…
continue reading
Welcome to the What’s Next! Podcast. I’ve met so many brilliant people as I traveled the globe and have had some fascinating conversations that I’ve wished had been recorded so I could share them with you - this podcast was a way for me to recreate those moments and let you in on some fantastic insights. My current conversations center around one objective: what's next for companies and individuals as they look to innovate and grow. I hope these conversations inspire you as much as they have ...
…
continue reading
…
continue reading
Alessandro Bogliari, CEO and Co-Founder of The Influencer Marketing Factory, a global influencer marketing agency, talks with great guests about influencer marketing, social media, the creator economy, social commerce and much more.
…
continue reading
The American healthcare system is one of the most innovative in the world. But it’s also riddled with complex challenges, such as access to affordable medications, inefficiency and administrative burdens, and communication barriers between providers. There’s clearly a better way—and at Surescripts, we have a unique sightline into what that may be. In this series, host Melanie Marcus, Chief Marketing Officer of Surescripts, sits down with today’s most inspiring and innovative leaders in healt ...
…
continue reading
Big tech is transforming every aspect of our world. But how, and at what cost? This season of Land of the Giants – The Disney Dilemma – focuses on Disney’s ability to weather the ups and downs of the business cycle and changing tastes and explores what has kept it successful for over 100 years. The entertainment giant has leveraged nostalgia and its intellectual property to build a beloved brand, but after an acquisition spree that included Marvel, Lucasfilm, and 20th Century Fox, can it sus ...
…
continue reading
Player FM -팟 캐스트 앱
Player FM 앱으로 오프라인으로 전환하세요!
Player FM 앱으로 오프라인으로 전환하세요!
))
Daily Deals
들어볼 가치가 있는 팟캐스트
스폰서 후원
T
Tinfoil Swans
Season 3 of the smash hit FX/Hulu show “The Bear” roared to life just days ago, but Will Poulter (the actor who plays fan-favorite Luca) and 2014 F&W Best New Chef Dave Beran had been prepping for weeks. Poulter — like his co-star Jeremy Allen White — staged with Beran at his Santa Monica restaurant Pasjoli to learn how to accurately portray a professional chef onscreen. The lessons went so well, Beran says he’d hire Poulter as a cook — even despite a messy mishap with a pastry bag. The two dished all about getting kitchen culture right on and offscreen, what it takes to be at the top of your craft, and the pure magic of a great restaurant service. Learn more about your ad choices. Visit podcastchoices.com/adchoices…
PwC's Next in Health
모두 재생(하지 않음)으로 표시
Manage series 3305757
PwC's Health Industries에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 PwC's Health Industries 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
Co -hosted by Glenn Hunzinger, US Health Industries leader, and Jennifer Colapietro, Consulting Commercial Leader, the Next in Health podcast series offers insights on the most important issues facing pharma, medtech and healthcare. PwC business leaders discuss the latest trends and their impact on health industries, whether it’s policy, AI, innovation, care delivery, business model reinvention or bold moves for the future. If it’s happening in health industries, we’re talking about it.
62 에피소드
공유
모두 재생(하지 않음)으로 표시
Manage series 3305757
PwC's Health Industries에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 PwC's Health Industries 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
Co -hosted by Glenn Hunzinger, US Health Industries leader, and Jennifer Colapietro, Consulting Commercial Leader, the Next in Health podcast series offers insights on the most important issues facing pharma, medtech and healthcare. PwC business leaders discuss the latest trends and their impact on health industries, whether it’s policy, AI, innovation, care delivery, business model reinvention or bold moves for the future. If it’s happening in health industries, we’re talking about it.
62 에피소드
All episodes
×
1 Taking a closer look at the Most Favored Nation Pricing Executive Order 16:47
16:47 
나중에 재생 
나중에 재생 
리스트 
좋아요 
좋아요16:47
나중에 재생 나중에 재생 리스트 좋아요 좋아요Tune in as Glenn Hunzinger, PwC’s Health Industries Leader, and Phil Scalfani, PwC’s Pharmaceutical and Life Sciences Consulting Leader, discuss the Trump administration’s executive order on Most Favored Nation (MFN) drug pricing and its far-reaching implications across the healthcare ecosystem. They break down what MFN pricing could mean for pharmaceutical companies, payers, PBMs, and the broader drug supply chain, and share perspectives on how organizations can navigate the uncertainty ahead. Discussion Highlights: The MFN executive order is a bold attempt to lower U.S. drug prices by benchmarking them against the lowest prices paid in other high-income countries Pharma companies may be forced to rethink global pricing strategies, balancing U.S. price cuts with potential increases or market exits abroad A proposed shift to direct-to-consumer drug access could disrupt traditional roles for pharmacies, distributors, and pharmacy benefit managers (PBMs) Companies are preparing for significant uncertainty by reassessing deals, modeling financial impacts, and closely monitoring upcoming rulemaking and potential legal developments Speakers: Glenn Hunzinger, Health Industries Leader, PwC Philip Sclafani, Partner, Pharma & Life Sciences, PwC Linked materials: Most Favored Nation prescription drug pricing Executive Order For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.…
Tune in as Glenn Hunzinger, PwC’s Health Industries Leader, connects with Matt Rich, PwC’s Pharma and Life Sciences R&D Leader, to unpack the recent disruption at the FDA and what it means for the pharmaceutical and biotech sectors. They discuss how companies can stay agile in the face of regulatory uncertainty, avoid preventable delays, and take practical steps to move programs forward with clarity. Discussion highlights: Ongoing restructuring at the FDA is creating uncertainty and delays in drug and device approvals, with wide-ranging impacts across the pharma, biotech and medtech landscape. While companies can’t control the regulatory environment, they can focus on improving internal speed, efficiency, and submission quality to keep programs moving forward Avoiding preventable missteps, or “foot faults,” in data, endpoints, and submission packages is critical to reducing review delays and regulatory pushback Diversifying risk by pursuing parallel regulatory pathways in other regions such as Europe and Japan can help accelerate access and reduce dependency on a single agency In the absence of a clear playbook, companies should focus on what they can control by applying past lessons, staying disciplined, and collaborating across the industry to support more efficient FDA review processes Speakers: Matt Rich, PwC’s Pharmaceutical and Life Sciences R&D Leader Glenn Hunzinger, Partner, Health Industries Leader, PwC Linked materials: Navigating the FDA disruption: 4 key actions for pharma For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.…
1 Strategic Shifts: Navigating China's Biotech Boom and Its Impact on US Pharma 11:46
11:46 나중에 재생 나중에 재생 리스트 좋아요 좋아요11:46
나중에 재생 나중에 재생 리스트 좋아요 좋아요Tune in as Glenn Hunzinger, PwC’s Health Industries Leader and Roel van den Akker, PwC’s Pharma and Life Sciences Deals Leader discuss the rapid rise of China’s biotech industry and what it means for U.S. pharmaceutical companies. They discuss the evolving role of Chinese biotech in the global innovation landscape and share perspectives on how U.S. pharmaceutical companies can thoughtfully assess opportunities, manage cross-border complexities, and build effective partnering and diligence strategies. Discussion highlights: China’s biotech industry is growing fast and becoming a global player, with U.S. companies increasingly looking to partner with Chinese firms on cutting-edge science U.S. pharma leaders are encouraged to move beyond skepticism and stay curious by building relationships, learning from local innovation, and exploring new partnership opportunities Successfully partnering with Chinese biotech firms requires a careful and well-structured approach that accounts for global complexity, protects data and IP, and uses creative deal structures like new company formations to manage risk and stay flexible U.S. companies need to be proactive in order to stay competitive by actively exploring global innovation, understanding the risks, and having a clear strategy to bring high-potential science to U.S. patients Speakers: Roel Van den Akker, Pharmaceutical and Life Sciences Deals Leader Glenn Hunzinger, Partner, Health Industries Leader, PwC Linked materials: China's rise as a biotech innovation hub: 4 key strategic questions for US biopharma executives For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.…
1 Navigating Healthcare’s Next Chapter Under the Trump Administration 28:08
28:08 나중에 재생 나중에 재생 리스트 좋아요 좋아요28:08
나중에 재생 나중에 재생 리스트 좋아요 좋아요Disclaimer: This episode was recorded on April 11th, 2025, and reflects the information available at the time of recording. As we know, America is in motion here, and so subsequent updates may not be reflected in this discussion as things continue to evolve and change. Tune in as PwC specialists from across the health industry share their insights on how recent policy shifts under the Trump administration could shape healthcare in the years to come. In this episode, Glenn Hunzinger, Jenny Colapietro, and guests Kelly Griffin, Phil Sclafani, and Ruchita Kewalramani break down the potential implications of proposed government healthcare cuts, tariff policy and agency workforce reductions, along with the growing role of AI in the industry. They also discuss how pharma, medtech, payers and providers can stay ahead amidst the uncertainty. Discussion highlights: Proposed funding cuts to major government healthcare programs like Medicare, Medicaid, and NIH could significantly disrupt access, affordability, and service delivery across the healthcare landscape. Workforce reductions at federal agencies like the Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), and Health and Human Services (HHS) may slow drug approvals, diminish oversight, and impact public health standards. New and evolving tariff policies are creating cost pressures across pharmaceutical and medtech supply chains, with potential downstream impacts on pricing, R&D, and patient access. The rapid adoption of AI in healthcare is creating new opportunities across diagnostics, R&D, and operations, while also raising concerns around governance and data privacy. To stay ahead, industry leaders must assess risks, strengthen agility, and uncover opportunities to innovate in today’s dynamic environment. Speakers: Kelly Griffin, Director, Health Policy Intelligence Institute, PwC Ruchita Kewalramani, Partner, Health Services PwC Phil Sclafani, Partner, Pharma & Life Sciences, PwC Glenn Hunzinger, Partner, Health Industries Leader, PwC Jenny Colapietro, Principal, Consulting Commercial Leader, PwC Linked materials: Health Policy and Intelligence Institute For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.…
Tune in as PwC's Pharmaceutical & Life Sciences Advisory Leader, Greg Rotz reflects on key market dynamics and explores how pharma leaders can tackle challenges including the $400 billion patent cliff, increasing competition, drug pricing pressures, and transformative disruptions shaping the industry. Discussion highlights: Understanding the scale and implications of the upcoming patent cliff and economic pressures from regulatory changes like the Inflation Reduction Act Examining heightened competition across therapeutic areas and the rapid emergence of rival treatments affecting market economics Highlighting the necessity for bold strategic moves and critical capabilities, including AI innovation, portfolio optimization, strategic partnerships, and comprehensive risk management Addressing disruptive forces such as geopolitical uncertainty, tariff impacts, and the rise of global innovation influencing pharmaceutical markets Emphasizing the urgency for pharma leaders to embrace innovation and transformative strategies to improve healthcare affordability, accessibility, and quality Speakers: Greg Rotz, Pharmaceutical & Life Sciences Leader,PwC Glenn Hunzinger, Health Industries Leader, PwC Jenny Colapietro, Consulting Commercial Leader, PwC Linked materials: Next in pharma 2025: The future is now Pharmaceutical and life sciences: US Deals 2025 outlook President Donald J. Trump’s healthcare agenda For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.…
Tune in as PwC specialists discuss the 2025 healthcare outlook, reflecting on 2024’s significant events and exploring how payers and providers can navigate rising costs, scrutiny, AI advances, and policy shifts with resilience and adaptability. Topics include: Medicare and Medicaid drive industry growth amid rising competition, market exits, M&A, AI adoption, and policy challenges. AI's potential to enhance healthcare delivery, improve workforce management, and optimize patient care. The care-at-home market is growing rapidly, driven by demand and cost efficiency, but sustainability remains a challenge. Encouragement for healthcare organizations to adapt and innovate in response to policy shifts and technological advancements. Speakers: Thom Bales, Health Services Leader, PwC Alena Taylor, Principal, PwC Ruchita Kewalramani, Principal, PwC Glenn Hunzinger, Health Industries Leader, PwC Jenny Colapietro, Consulting Commercial Leader, PwC Linked materials: Next in Health: The 2025 Outlook for Health Services: https://www.pwc.com/us/en/industries/health-industries/library/healthcare-trends.html Health Policy and Intelligence Institute: https://www.pwc.com/us/en/industries/health-industries/health-policy-and-intelligence-institute.html For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.…
1 Health Industries: U.S. Deals Outlook for 2025 and Beyond 25:18
25:18 나중에 재생 나중에 재생 리스트 좋아요 좋아요25:18
나중에 재생 나중에 재생 리스트 좋아요 좋아요Tune in to listen as PwC’s leaders Roel van den Akker and Nick Donkar provide insights into the 2024 deals landscape and offer a preview of what lies ahead. Topics include: Key topics include: A look back at M&A activity in health industries in 2024 The challenges and potential impediments that could affect deal volumes in the coming year How artificial intelligence and tech innovations are reshaping the volume and nature of healthcare transactions Key trends and developments to watch for with emphasis on growth, strategic assessments and regulatory factors Speakers: Roel van den Akker, Pharmaceutical and Life Sciences Deals Leader, PwC Nick Donkar, Health Services Deals Leader, PwC Jenny Colapietro, Consulting Commercial Leader, PwC Linked materials: https://www.pwc.com/us/en/industries/health-industries/library/health-services-deals-outlook.html https://www.pwc.com/us/en/industries/health-industries/library/pharma-life-sciences-deals-outlook.html For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.…
Tune in as authors of PwC's U.S. Healthcare Climate Survey discuss key findings and provide insights into understanding healthcare organizations' responses to climate change, the integration of climate strategies, and the challenges faced in implementation. Key topics include: The survey's background, focus, and objectives that address the prioritization of climate strategies by healthcare organizations in response to climate change impacts Differences in climate strategy approaches across sectors, reveals significant disparities in priorities and operational needs amongst payers, providers, pharmaceutical, and medtech companies Key statistics and insights on organizational behavior and perceptions related to climate strategy integration, sustainability, and the impact on human health Considerations for healthcare stakeholders to enhance climate strategy implementation and address the evolving needs of diverse communities affected by climate change Speakers: Mackenzie Daly, Partner, PwC Stacie Gitkin, Director, PwC Jenny Colapietro, Consulting Commercial Leader, PwC Linked materials: https://www.pwc.com/us/en/industries/health-industries/library/impact-of-climate-change-on-human-health.html For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.…
1 PwC's U.S. Healthcare Consumer Insights and Engagement Survey 20:40
20:40 나중에 재생 나중에 재생 리스트 좋아요 좋아요20:40
나중에 재생 나중에 재생 리스트 좋아요 좋아요Tune in as authors of PwC's U.S. Healthcare Consumer Insights and Engagement Survey discuss key findings and provide insights into understanding consumer concerns around healthcare costs, the adoption of tech-enabled healthcare, trust in the healthcare system and how we can take action. Key topics include: The survey's background, focus and objectives that will address ongoing consumer concerns and distrust in the healthcare system Generational and financial differences reveal significant disparities in healthcare experiences and engagement amongst various age groups Notable key statistics and insights on consumer behavior and perceptions related to trust, affordability, delayed care and digital health across the health ecosystem Considerations for healthcare stakeholders to enhance care delivery and to address the evolving needs of diverse patient populations Speakers: Thom Bales, Health Services Leader, PwC Keith Fengler, Customer Service and Channels Lead, PwC, Omar Chane, Principal, PwC. Jenny Colapietro, Consulting Commercial Leader, PwC Linked materials: https://www.pwc.com/us/en/industries/health-industries/library/healthcare-consumer-insights-survey.html For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.…
1 Next in medtech: Unlocking future growth in 3 strategic steps 13:14
13:14 나중에 재생 나중에 재생 리스트 좋아요 좋아요13:14
나중에 재생 나중에 재생 리스트 좋아요 좋아요How can medtech companies drive growth in today's market? Tune in as PwC specialists return to share key insights and strategies to help medtech companies invest in the capabilities required to compete in the future while aiming to exceed near-term expectations for growth and margin improvement. Key topics include: Challenges currently faced by medtech companies Reevaluating business models and new ways to play Driving returns on historical investments in technology by leveraging data and transforming legacy processes Embracing a “high-tech” mindset to enable change and creating a culture of empowered decision makers Unlocking value through strategic M&A Speakers: James Woods, Principal, PwC Kevin McLellan, Principal, Strategy&, PwC Luna Corbetta, Principal, PwC Jenny Colapietro, Consulting Commercial Leader, PwC Materials: https://www.pwc.com/us/en/industries/health-industries/medical-technology/medtech-industry-insights.html For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.…
What can the health industry expect from a second Trump administration? Tune in to hear what executives should watch over the next few months and years to come. Key topics include: President-elect Trump's healthcare agenda and his focus on deregulation, flexibility and choice, and accessibility Potential implications for medicare, the ACA and IRA drug negotiations What to watch in the first 100 days Speakers: Kelly Griffin, Director, Health Policy and Intelligence Institute Jenny Colapietro, Consulting Commercial Leader, PwC Linked materials: https://www.pwc.com/us/en/industries/health-industries/library/election-2024-trump-health-agenda.html For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.…
1 Boardroom essentials: Securing a seat on an emerging company board 16:11
16:11 나중에 재생 나중에 재생 리스트 좋아요 좋아요16:11
나중에 재생 나중에 재생 리스트 좋아요 좋아요Tune in as PwC specialists discuss best practices for securing a seat on an emerging company board. Key topics include: Types of emerging companies Responsibilities of serving on emerging company boards Five strategies for securing a board position Importance of industry-specific expertise and continuous learning Speakers: Holly Reeves, Partner, Emerging Company Solutions Market Leader, Health Industries, PwC US Carin Robinson, Director, Governance Insights Center, PwC US Jenny Colapietro, Consulting Commercial Leader, PwC For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.…
1 PwC's 2025 Medical cost trend report reveals rising healthcare costs 21:54
21:54 나중에 재생 나중에 재생 리스트 좋아요 좋아요21:54
나중에 재생 나중에 재생 리스트 좋아요 좋아요Tune in as authors of PwC's 2025 Medical Cost Trend Report: Behind the Numbers, discuss key findings and provide what employers should consider to manage rising healthcare costs. Key points include: Cost projections: The highest medical cost trend in 13 years, with an 8% increase for the group market and 7.5% for the individual market Key drivers: Inflation, providers' cost-control efforts, increased use of prescription drugs, and new innovative therapies Strategic adjustments: Employers should revise benefit plans and consider innovative solutions to manage rising costs while ensuring access to quality care Speakers: Thom Bales, Health Services Advisory Leader, PwC Phil Sclafani, Principal, Pharmaceutical and Life Sciences, PwC Julian Levin, Principal, Actuarial Leader, PwC Jenny Colapietro, Consulting Commercial Leader, PwC For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.…
1 The importance of physician enablement to our health ecosystem 18:03
18:03 나중에 재생 나중에 재생 리스트 좋아요 좋아요18:03
나중에 재생 나중에 재생 리스트 좋아요 좋아요Tune into this episode of PwC's Next in Health to hear Strategy& Principal, Igor Belokrinitsky, in discussion with PwC Strategy& Director, Rohit Nayak, PwC Strategy& Senior Manager, Sri Murthy Guru and PwC Strategy& Senior Associate, Cailin Hong, on what physicians are seeking from payers, health systems and management services organizations (MSOs), to help improve the practice of medicine. This episode includes: Emerging business models and solutions that can enhance the physician experience The role of payers and providers in driving physician enablement within the health ecosystem Actions health organizations should consider to help support and encourage their physicians For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.…
1 How emerging companies are navigating growth in the health industry 21:13
21:13 나중에 재생 나중에 재생 리스트 좋아요 좋아요21:13
나중에 재생 나중에 재생 리스트 좋아요 좋아요Tune in as PwC specialists discuss how emerging companies (private, pre-IPO) are navigating growth in the health industry. Key topics include: The journey and milestones of emerging companies in the life sciences, biotech and medical technology fields, including capital raising, product development and IPO preparation Common pitfalls and best practices for managing diverse interests from investors and stakeholders Examples of how emerging companies are leveraging AI and other technologies to prioritize programs, design clinical trials and communicate value proposition Speakers: Holly Reeves, Health Industries - Emerging Company Solutions Market Leader, PwC US Christian Jester, Technology, Media & Telecommunications - Emerging Company Solutions Market Leader, PwC US Jenny Colapietro, Health Industries Vice Chair, PwC, US For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.…
P
PwC's Next in Health
Tune in as PwC specialists discuss the 2024 outlook for healthcare and how the sector can grow and innovate amid economic challenges and uncertainty. Key Topics include: Major forces impacting the sector: economic pressure, rising costs, labor shortage, and expensive drugs Ways to overcome compression and deliver value: industry-wide transformation, tech enabled business model reinvention, transactions and deals to drive transformation, and building trust Speakers: Laura Robinette, Health Industries Trust Solutions Leader, PwC, US Thom Bales, Health Services Leader, PwC, US Jenny Colapietro, Health Industries Vice Chair, PwC, US For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.…
P
PwC's Next in Health
Tune in to hear PwC specialists discuss strategies to reinvent the pharma business model and drive growth in the pharmaceutical industry. Key topics include: The headwinds for pharma are real and sustained Rethinking the innovation strategy Accelerate using AI and analytics Lower costs M&A as a catalyst for transformation Protecting the enterprise Speakers: Jenny Colapietro, Health Industries Vice Chair, PwC Glenn Hunzinger, Pharmaceutical and Life Sciences Leader, PwC Greg Rotz, Pharmaceutical and Life Sciences Advisory Leader, PwC For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.…
P
PwC's Next in Health
Tune in to hear PwC Deals leaders discuss preparing for deals in 2024, exploring the current state of the deals market and sharing valuable insights from their newly released 2024 deals outlook. Key topics include: Fundamental changes and strategy trends for 2024 and how it’s shaping the health services and pharma landscapes The role of the regulators and their impact on deals Business model reinvention and the use of new technology to acquire better data and how it’s shaping the deals environment for 2024 What’s on the horizon: Key success factors for good deal making in 2024 Speakers: Roel van den Akker, Pharmaceutical and Life Sciences Deals Leader, PwC Nick Donkar, Health Services Deals Leader, PwC Jenny Colapietro, Health Industries Vice Chair, PwC Igor Belokrinitsky, Strategy& Principal, PwC For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.…
P
PwC's Next in Health
1 Transforming healthcare collaboration through the power of health ecospheres 15:36
15:36 나중에 재생 나중에 재생 리스트 좋아요 좋아요15:36
나중에 재생 나중에 재생 리스트 좋아요 좋아요Tune in to hear PwC specialists discuss how health ecospheres can provide a transformative model for organizations to collaborate and address large-scale healthcare problems. Topics include: Identifying areas of historical shortcomings Understanding strengths and capabilities Determining the role within the ecosphere Speakers: Dave Powell, Enterprise Strategy Lead Principal, PwC Tyler Mansfield, Enterprise Strategy Principal, PwC Jenny Colapietro, Health Industries Vice Chair, PwC Igor Belokrinitsky, Strategy& Principal, PwC For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.…
P
PwC's Next in Health
1 Harnessing data insights: Revolutionizing healthcare and costs for patients with complex chronic conditions 33:17
33:17 나중에 재생 나중에 재생 리스트 좋아요 좋아요33:17
나중에 재생 나중에 재생 리스트 좋아요 좋아요Tune in as health leader, author and entrepreneur, Stephen Pollak, PhD, shares how the outcomes of his research in hemodialysis populations and beyond are paving the path for data-driven solutions that inform and integrate care for patients with complex chronic conditions. Topics include: Patient medical records playing a vital role in improving medical practice outcomes and costs Shifting the focus to emphasize on a results-oriented approach to inform decision-making Overcoming sustainability and affordability challenges through clinical models The role of AI in healthcare Speakers: Stephen Pollak, PhD Igor Belokrinitsky, Strategy& Principal, PwC For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.…
P
PwC's Next in Health
1 The secret to attracting and retaining healthcare consumers 19:27
19:27 나중에 재생 나중에 재생 리스트 좋아요 좋아요19:27
나중에 재생 나중에 재생 리스트 좋아요 좋아요Tune in to hear PwC specialists discuss re-engineering the healthcare ecosystem by engaging healthcare consumers. Topics include: Evaluating the consumer experience and engagement Trends in the market to help organizations develop and focus on their mission to enhance consumer experience and key investments Three capabilities that are needed to deliver on the promise of personalization, low cost, experience, and convenience Speakers: Derek Gaasch, Customer Transformation Principal, PwC Elizabeth Carlson, Customer Transformation Director, PwC Kristen Knudson, Enterprise Transformation Senior Manager, PwC Igor Belokrinitsky, Strategy& Principal, PwC For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.…
P
PwC's Next in Health
1 Transforming Ukraine’s healthcare infrastructure for a sustainable future 22:53
22:53 나중에 재생 나중에 재생 리스트 좋아요 좋아요22:53
나중에 재생 나중에 재생 리스트 좋아요 좋아요Tune in to hear Barrett Baker of Project Horizon from the Sunflower Network, and Dan Solchanyk from Razom, discuss how to strengthen Ukraine’s healthcare infrastructure both for the near and the long term. Topics include: Sunflower Network’s mission is to deliver aid and infrastructure to communities in crisis. Project Horizon furthers this mission by building a hospital in Ukraine, empowering local healthcare workers with the infrastructure needed to deliver high quality care to their patients, and setting the stage for a larger rebuild of Ukraine’s healthcare system Razom Health: Providing critical supplies, equipment, training and preparing for long-term sustainability Challenges and strategies to find the right balance between speed, providing high quality enduring solutions, and mitigating risks Examples of how determination and perseverance of the Ukraine communities are pioneering innovative healthcare solutions Speakers: Barrett Baker, Project Lead, Sunflower Network Dan Solchanyk, Program Director, Razom Health Igor Belokrinitsky, Strategy& Principal, PwC Jenny Colapietro, Health Industries Vice Chair, PwC For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.…
P
PwC's Next in Health
1 Future-proofing behavioral health care: Innovations to ensure no one is left behind 14:38
14:38 나중에 재생 나중에 재생 리스트 좋아요 좋아요14:38
나중에 재생 나중에 재생 리스트 좋아요 좋아요Tune in to hear Chris Barnett, Chris Barnett, CEO of ABA Centers of America, discuss his approach to a comprehensive healthcare system, with a specific emphasis on new models, technologies, and algorithms that promote inclusivity for improved behavioral health care outcomes. Topics include: The origin of Applied Behavioral Analysis (ABA) and how it seek to change lives by helping change behavior of patients on the spectrum, improving their lives and those around them. Examples of offering play-based therapies to achieve better outcomes and experiences for patients that are non-verbal Challenges and issues faced in the behavioral health space and solutions to help prevent workforce burnout and increase benefit options for staff How ABA is using AI and technology to gain better data and insights Speakers: Chris Barnett, CEO, ABA Centers of America Jenny Colapietro, Health Industries Vice Chair, PwC Igor Belokrinitsky, Strategy& Principal, PwC For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.…
P
PwC's Next in Health
1 Key strategies for global pharma companies to reduce risk and drive growth in the China market 15:52
15:52 나중에 재생 나중에 재생 리스트 좋아요 좋아요15:52
나중에 재생 나중에 재생 리스트 좋아요 좋아요Tune in to hear PwC specialists discuss their recently published article: How a local-first strategy in China can help global pharma and life sciences players reduce risk and drive growth. Topics include: Sharing key strategies for pharma companies contemplating localization in China, offering valuable insights on maximizing business growth while mitigating risks in the Chinese market Three approaches organizations can consider to competing at a local level in China Impacts to different functions across the value chain such as R&D, supply chain, and IT Speakers: Nalneesh Gaur, Partner, Pharmaceutical and Life Sciences Cybersecurity, PwC Ben Rhee, Principal, Pharmaceutical and Life Sciences Enterprise Strategy and Value, PwC Igor Belokrinitsky, Strategy& Principal, PwC For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.…
P
PwC's Next in Health
1 How technology is helping to transform behavioral and mental health care across the globe 22:45
22:45 나중에 재생 나중에 재생 리스트 좋아요 좋아요22:45
나중에 재생 나중에 재생 리스트 좋아요 좋아요People across the world are suffering from behavioral and mental health challenges. Tune in to hear Eric Hren, Chief Growth Officer at Innowell, discuss how technology can help provide better services and solutions for patients, clinicians and employers. Topics include: Getting to know Innowell: What it does, what it offers, and the problems it solves Reaching various populations by increasing digitization to improve wellbeing and productivity, providing real-time care and reducing waitlist time Designing technology to be inclusive across all populations as well as accessible to various care settings Future growth of Innowell: Providing preventative care and solutions to unlock better outcomes for patients, clinicians, and organizations Speakers: Eric Hren, Chief Growth Officer, Innowell Igor Belokrinitsky, Strategy& Principal, PwC For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.…
P
PwC's Next in Health
Tune in to hear PwC specialists discuss the functionality and benefits of using GenAI in health care. Topics include: How GenAI is being used today GenAI helping health insurers drive affordability of healthcare Health organizations managing risks posed by GenAI Speakers: Inshita Wij, Strategy& Director, PwC Sri Murthy, Strategy& Director, PwC Igor Belokrinitsky, Strategy& Principal, PwC For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.…
P
PwC's Next in Health
1 What to know about using GenAI in the pharma and life sciences industry 33:43
33:43 나중에 재생 나중에 재생 리스트 좋아요 좋아요33:43
나중에 재생 나중에 재생 리스트 좋아요 좋아요Tune in to hear PwC specialists discuss using GenAI in the pharma and life sciences industry. Topics include: Key considerations for new technology and deploying GenAI responsibly Key elements to consider for monitoring regulatory activity The future of technology, adoption and upskilling within organizations Speakers: Siddhartha Bhattacharya, Cloud & Digital Principal, PwC Ilana Golbin Blumenfeld, Products & Technology Director, PwC Igor Belokrinitsky, Strategy& Principal, PwC For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.…
P
PwC's Next in Health
1 The SCAN Group reinvents coverage and care for the seniors 29:29
29:29 나중에 재생 나중에 재생 리스트 좋아요 좋아요29:29
나중에 재생 나중에 재생 리스트 좋아요 좋아요Tune in to hear how the SCAN Group is expanding their Medicare Advantage plan by launching new care entities that aim to address problems of older adults. Topics include: •Addressing national-scale industry issues such as affordability and equity, and the role SCAN Group is playing •How attributes and mindset make the legal department a great fit to oversee health equity •Initiatives and data-driven solutions to help close the gap around racial disparities •What’s next for the SCAN Group: New affiliations, products, and innovation Speakers: Sachin Jain, M.D., CEO, SCAN Group Renee Delphin-Rodriguez, Chief Legal Office and General Counsel, SCAN Group Igor Belokrinitsky, Strategy& Principal, PwC For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.…
P
PwC's Next in Health
1 Transforming consumer and patient engagement in life sciences 15:52
15:52 나중에 재생 나중에 재생 리스트 좋아요 좋아요15:52
나중에 재생 나중에 재생 리스트 좋아요 좋아요Tune in to hear PwC specialists discuss how life sciences companies are engaging better with consumers and patients and rethinking engagement, the channels utilized and how to utilize data and technology to create meaningful impact. Topics include: •What elements create a good customer experience and why it’s important •Four key principles to creating a good customer experience •Restructuring roles and focus in commercial and medical organizations as well as identifying organizational growth •Utilizing data and technology along with the new evolution of Generative AI Speakers: Elizabeth Otterman, Customer Strategy and Insights Principal, PwC Jacquie Newland, Services and Channels Director, PwC Igor Belokrinitsky, Strategy& Principal, PwC For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.…
P
PwC's Next in Health
1 Key findings from PwC's medical trend cost report, Behind the Numbers 2024 17:26
17:26 나중에 재생 나중에 재생 리스트 좋아요 좋아요17:26
나중에 재생 나중에 재생 리스트 좋아요 좋아요Tune in to hear PwC specialists share key findings from their medical cost trend report, discussing healthcare affordability and its implications for employers and consumers. Topics include: The Macroeconomics environment: The impact of inflation How the workforce shortage and physician consolidation are impacting cost and patient care Increasing cost of drugs and health therapies Employer perspectives on coverage and cost sharing Outlook for healthcare systems and health plans in an ever-changing and innovative environment Speakers: Thom Bales, Health Services Sector Leader, PwC Derek Skoog, Principal, PwC Julian Levin, Principal, PwC Jenny Colapietro, Health Industries Vice Chair, PwC Igor Belokrinitsky, Strategy& Principal, PwC For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.…
플레이어 FM에 오신것을 환영합니다!
플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.
Daily Deals
PwC's Next in Health와 비슷한 콘텐츠
A top podcast for healthcare leaders, with over one million downloads, Radio Advisory is your weekly download on how to untangle the industry's most pressing challenges to help leaders like you make the best business decisions for your organization. From unpacking major trends in care delivery—like site-of-care shifts and the rise of high-cost drugs—to demystifying stakeholder dynamics, to shining a spotlight on priorities that may get overlooked, we're here to help. Our hosts and seasoned r ...
…
continue reading
Call them changemakers. Call them rule breakers. We call them Redefiners. And in this provocative podcast, we explore how daring leaders from across industries and around the globe are redefining their organizations—and themselves—to create extraordinary impact in today’s rapidly changing world. In each episode, Russell Reynolds Associates Leadership Advisor Hoda Tahoun and former CEO Clarke Murphy host engaging, purposeful conversations with leaders in and out of the business world who shar ...
…
continue reading
Rachel Cooke is your guide to leadership and communication, helping you craft a workplace environment you can feel good about. She’ll share tips to help you balance your work and personal life, effectively invest your time, and be mindful about where you’re devoting your energy. Let Rachel help you navigate your path to success—however you define it.
…
continue reading
Wharton faculty and industry leaders discuss their latest research, books, and relevant business topics. Hosted on Acast. See acast.com/privacy for more information.
…
continue reading
Some Goodness is hosted by Richard Ellis, a seasoned sales leader passionate about inviting top business minds to share their wisdom. Each episode is only 15-20 minutes, perfect for your commute or workout.
…
continue reading
Welcome to the What’s Next! Podcast. I’ve met so many brilliant people as I traveled the globe and have had some fascinating conversations that I’ve wished had been recorded so I could share them with you - this podcast was a way for me to recreate those moments and let you in on some fantastic insights. My current conversations center around one objective: what's next for companies and individuals as they look to innovate and grow. I hope these conversations inspire you as much as they have ...
…
continue reading
…
continue reading
Alessandro Bogliari, CEO and Co-Founder of The Influencer Marketing Factory, a global influencer marketing agency, talks with great guests about influencer marketing, social media, the creator economy, social commerce and much more.
…
continue reading
The American healthcare system is one of the most innovative in the world. But it’s also riddled with complex challenges, such as access to affordable medications, inefficiency and administrative burdens, and communication barriers between providers. There’s clearly a better way—and at Surescripts, we have a unique sightline into what that may be. In this series, host Melanie Marcus, Chief Marketing Officer of Surescripts, sits down with today’s most inspiring and innovative leaders in healt ...
…
continue reading
Big tech is transforming every aspect of our world. But how, and at what cost? This season of Land of the Giants – The Disney Dilemma – focuses on Disney’s ability to weather the ups and downs of the business cycle and changing tastes and explores what has kept it successful for over 100 years. The entertainment giant has leveraged nostalgia and its intellectual property to build a beloved brand, but after an acquisition spree that included Marvel, Lucasfilm, and 20th Century Fox, can it sus ...
…
continue reading
Player FM -팟 캐스트 앱
Player FM 앱으로 오프라인으로 전환하세요!
Player FM 앱으로 오프라인으로 전환하세요!
))
